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ABSTRACT  
A new Copper-based compound was synthesized from coordination reaction of diethylenetriamine and copper ions, using copper chloride 
dehydrate in ethanol. This synthesized compound was characterized by a number of spectroscopic methods including UV, IR, and by elemental 
analysis. IR calculated vibration was carried out HyperChem 08 software, whereas analgesic activity was evaluated in vivo against acetic acid 
induced pain in mice model. Results obtained from theoretical and experimental investigations demonstrate the high analgesic effect of copper 
complex towards acetic acid with percentages of 85.39 and 89.68% respectively, which is comparable with that of aspirin and tramadol (18.9 
and 79.78 % respectively).   
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INTRODUCTION 
Pain is defined as an unpleasant sensory and emotional 
experience associated with actual or potential tissue injury. 
Painful transmission is a complex phenomenon involving 
electrophysiological and neurochemical mechanisms 
[1].Traumatic, inflammatory or ischemic lesions cause the 
release of damaged chemicals. These substances can either 
directly activate the nociceptors (bradykinins, potassium 
ions, hydrogen, nitric oxide, histamine and serotonin) or 
sensitize the nociceptors to other stimuli. In addition, 
Prostaglandins and leukotrienes, play a role of sensitizers of 
nociceptors acting on other substances such as the peptides 
involved in the transmission of the pain message. Substance 
P is best known as a neuropeptide (neurotransmitter) and 
plays a primordial role in nociception and has a vasodilatory 
action at the origin of algogenic inflammation [2]. An 
analgesic is a drug used in the fight against pain. Generally, 
analgesic drugs are associated with various undesirable 
gastrointestinal effects [3]. From these reasons, there is the 
need for the search of new safe analgesics. 
In this study, Copper-based compound was predicted for 
their analgesic activity using the web tool PASS online, then 
synthesized, characterized and investigated in vivo for their 
analgesic effect using acetic acid intraperetenialy injection in 
mice model. This complex was synthesized from the 
coordination reaction of copper (II) chloride dehydrate and 
diethylenetriamine in ethanolic solution.      
MATERIALS AND METHODS 
MATERIALS  
The chemicals was purchased and used without further 
purification: diethylenetriamine, copper chloride dehydrate 
(Sigma–Aldrich), Acetic acid (Merck). Infrared spectra (IR) 
were obtained, as KBr disks, on a Schimadzu FTIR-8400S 
spectrophotometer. The electronic absorption spectra in the 
200–900 nm range were recorded on a UV-1800Schimadzu 
UV–visible spectrophotometer. Elemental analysis (C, H, and 
N) was carried out with a EuroVector EA3000 instrument. 
Synthesis of diethylenediamine copper complex  
Ethanolic solution of  CuCl2.2H2O (0.01 mol, 1.0748 g) was 
added to diethylenetriamine (0.01 mol, 1.0317 g), the 
mixture was refluxed for 1h at 78 °C. After cooling, the 
precipitate solid was filtered, isolated and washed several 
time with ethanol (Scheme 1). 
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Scheme 1. Synthesis of copper complex 
Yield 86%. UV–Vis (H2O) λmax (nm) 247. IR (KBr, cm–1): νmax: 3276-3243 (br, NH2), Anal. Calcd for C4H15Cl2CuN3O: C, 18.79; H, 
5.91; N, 16.44. Found: C, 19.52; H, 5.59; N, 16.83%. 
 
Theoretical vibration data prediction   
Calculated vibration was carried out HyperChem 08 
software, with molecular mechanic force field (MM+) and 
semi-empirical AM1, PM3 methods [4]. 
In silico analgesic activity prediction 
The web tool PASS online was employed for analgesic 
activity predictions, in which the obtained values are the 
results of the difference between the probability of 
molecular activity and inactivity values [5].    
In vivo analgesic activity evaluation  
In this assay, female mice were employed, divided into five 
groups of five animals each (n = 5). These mice were 
subjected to fasting for 12 h before the experiment but 
allowed free access to water except during the experiment. 
Mice were intra-peritoneally injected with 0.1% (v/v) acetic 
acid to induce writhes after 60 minutes of oral treatment 
with water as a vehicle, Copper complex (5 and 10 mg/kg) or 
aspirin (100 mg/kg) as a positive control. Number of 
abdominal constrictions was counted over a period of 30 
minutes by an observer unaware of the treatment after 5 
minutes of injection. The percentage inhibition of writhing 
reflex was calculated using the formula: % inhibition 
(protection) = 100 x (Nc–Nt)/Nc, where Nc = mean number 
of writhes in control Nt = mean number of writhes in test [6]. 
RESULTS AND DISCUSSION  
Chemistry  
Copper complex was prepared from the reaction between 
copper chloride dehydrate and diethylenetriamine. 
The infrared spectra of the synthesized complex indicate the 
presence of the amine group (NH2) at 3276-3243 cm-1. Also, 
the appearance of new bands between 500 and 600 cm-1 is 
due to the coordination of copper ions with nitrogen of the 
amine. This confirms that the synthesis of the complex has 
taken place (Fig 1). 
     
 
Fig 1: FT-IR spectrum of Copper complex 
 
In addition, experimental analysis data are in perfect 
agreement with the theritical data of this  compound.  
Furthermore, an excellent correlation was obtained between 
experimental and calculated IR vibration in the both 
methods, AM1 and PM3, with correlation coefficient values of 
0.998 and 0.991 for the synthesized complex (Fig 2).
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Fig 2: Graphical correlations between the experimental and calculated IR vibration of Complex obtained by AM1 and PM3 semi-
empirical methods (cc = correlation coefficient). 
 
In silico analgesic activity prediction 
Pain is one of the most important health problems because 
of its prevalence and the disability it can cause. Chronic pain 
may be the result of inflammatory diseases or tissue damage 
such as nerve damage in the case of neuropathic pain. In 
Europe, chronic pain affects about 17 to 45% of the 
population [7]. In addition, chronic pain is often resistant to 
existing therapy; for this reason, there is a great need for 
new drug research [8]. In recent years, computational 
methods were used as a first step for drug discovery and 
development. This approaches, have an exclusive advantage 
of being able to evaluate the biological effect of drug-
candidate substances before they are synthesized. According 
to these efficient approaches, the synthesized copper 
complex was investigated in silico for their analgesic activity. 
The predicted results (Fig 3) demonstrate that the 
synthesized copper complex exhibit an excellent analgesic 
effect with probability of 85.39%, followed with the opioid  
drug; Tramadol with 83.83% and no-opioid drug; aspirin 
with 18.9%. From these results, the synthesized copper 
complex has a similar effect of the opioid drug; Tramadol 
which exhibit their spinal analgesic effect via μ2, κ1, δ2 
receptors [9]. 
 
 
Fig 3: In silico prediction of analgesic potential of Copper complex, Tramadol and Aspirin 
 
In vivo analgesic activity evaluation  
The intraperitoneal injection of acetic acid in mice causes a 
pain syndrome that results in characteristic writhing type of 
stretching movement of the hind legs and the dorso-ventral 
musculature. These events are strongly related to the 
sensitization of the nociceptive receptors that will induce the 
synthesis of PGE2, PGF2α, serotonin and histamine [10]. This 
assay has the great interest in analgesic drugs screening [11]. 
The analgesic substances cause the decrease in these 
contortions. In this study, the obtained results presented in 
Fig 4 show that the administration of 10 and 5 mg/kg of the 
synthesized copper complex and 100 mg/kg of aspirin 
exerted a protective effect against the pain caused by the 
acetic acid. The potent inhibitory effect of abdominal 
contractions is recorded at the doses of 10 and 5 mg/kg, 
which exhibited an inhibitory effect of 89.68 and 76.07 % 
respectively. These effects are better than that of 100 mg/kg 
aspirin (79.78%). In literature, several sutdies demostrate 
that copper represents an oligoelement with high analgesic 
activities [12]. Also, demonstare that copper complexes of 
anti-inflammatory enchanced analgesic effect of these drugs. 
In conclusion, the experimental results are in good 
correlation with theoretical results. From these results, the 
synthesized copper complex could be an analgesic candidate 
drug, which proposed act on the peripheral and central 
nervous systems.  
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Fig 4: Analgesic activity of Copper complex (5 and 10 mg/kg) and aspirin (100 mg/kg) 
 
CONCLUSIONS  
We conclude that the synthesized copper complex could be 
an analgesic candidate drug, which proposed act on the 
peripheral and central nervous systems.  
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